Probing Combined Experimental and Computational Profiling to Identify N-(benzo[d]thiazol-2-yl) Carboxamide Derivatives: A Path to Potent α-Amylase and α-Glucosidase Inhibitors for Treating Diabetes Mellitus
Molecules · 2026
DOI: 10.3390/molecules31040751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Fakhria A Al-Joufi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72341, Aljouf, Saudi Arabia. Hauptthemen laut MEDLINE: Glycoside Hydrolase Inhibitors, alpha-Amylases, alpha-Glucosidases, Hypoglycemic Agents. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah bint Abdulrahman University, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Themen: Diabetes mellitus
Abstract (Originalsprache)
A novel series of benzothiazole scaffolds were presented to test their in vitro α-amylase and α-glucosidase activities for combating diabetes mellitus, which is one of the most rapidly growing diseases. The tested compounds were elucidated structurally by various spectroscopic techniques like 1H NMR, 13C NMR and HRMS. All compounds exhibited a varied range of inhibitory activities against targeted α-amylase and α-glucosidase enzymes, with IC50 values of 1.58 ± 1.20 to 7.54 ± 3.60 µM (α-amylase) and 2.10 ± 1.10 to 8.90 ± 4.10 (α-glucosidase), respectively. The obtained results were compared with the standard acarbose drug, with IC50 values of 0.91 ± 0.20 µM (α-amylase) and 1.80 ± 1.10 µM (α-glucosidase). Specifically, methyl 2-amino-4-((6-methoxypyridin-3-yl)methoxy)benzo[d]thiazole-6-carboxylate (5c) and methyl 4-((6-methoxypyridin-3-yl)methoxy)-2-(thiazole-2-carboxamido)benzo[d]thiazole-6-carboxylate (6b) emerged as potent inhibitors of α-amylase and α-glucosidase enzymes. These potent compounds were further screened for in silico molecular docking studies to investigate possible binding interactions with active sites of targeted enzymes, and results obtained demonstrated that potent compounds exhibited stronger binding affinities toward anti-diabetic enzymes compared to the positive control acarbose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72341, Aljouf, Saudi Arabia.
- Department of Pharmaceutical Sciences, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Makkah, Saudi Arabia.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Alquwayiyah 11961, Riyadh, Saudi Arabia.
- Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Riyadh, Saudi Arabia.
- Department of Zoology, University of Swat, Swat 19200, Pakistan.
ORCID-Profile: Fakhria A Al-Joufi, Nawal Al-Hoshani, Ghulam Nabi
Förderung
- Princess Nourah bint Abdulrahman University
- Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
Zitieren
APA
Al-Joufi, F. A., Mojally, M., Alwethaynani, M. S., Al-Hoshani, N., & Nabi, G. (2026). Probing Combined Experimental and Computational Profiling to Identify N-(benzo[d]thiazol-2-yl) Carboxamide Derivatives: A Path to Potent α-Amylase and α-Glucosidase Inhibitors for Treating Diabetes Mellitus. Molecules. https://doi.org/10.3390/molecules31040751
Vancouver
Al-Joufi FA, Mojally M, Alwethaynani MS, Al-Hoshani N, Nabi G. Probing Combined Experimental and Computational Profiling to Identify N-(benzo[d]thiazol-2-yl) Carboxamide Derivatives: A Path to Potent α-Amylase and α-Glucosidase Inhibitors for Treating Diabetes Mellitus. Molecules. 2026. doi:10.3390/molecules31040751
BibTeX
@article{AlJoufi2026,
author = {Al-Joufi, Fakhria A and Mojally, Mariam and Alwethaynani, Maher S and Al-Hoshani, Nawal and Nabi, Ghulam},
title = {Probing Combined Experimental and Computational Profiling to Identify N-(benzo[d]thiazol-2-yl) Carboxamide Derivatives: A Path to Potent α-Amylase and α-Glucosidase Inhibitors for Treating Diabetes Mellitus},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31040751}
}
EUVIMED